Andrea Tan
Stock Analyst at Goldman Sachs
(0.12)
# 3,748
Out of 4,877 analysts
46
Total ratings
14.29%
Success rate
-49.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $100 → $112 | $97.62 | +14.73% | 10 | Jun 11, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $1.74 | +359.77% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $40.01 | +27.48% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $6.62 | +307.85% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $8.03 | -25.28% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $16.09 | +92.67% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $0.62 | +224.62% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $3.76 | -46.74% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $139.16 | +14.98% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $3.49 | +587.68% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.15 | +249.34% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $300.16 | +24.93% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $13 | $11.28 | +15.25% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $4 | $1.43 | +179.72% | 2 | May 24, 2022 |
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $100 → $112
Current: $97.62
Upside: +14.73%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $1.74
Upside: +359.77%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $40.01
Upside: +27.48%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $6.62
Upside: +307.85%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $8.03
Upside: -25.28%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $16.09
Upside: +92.67%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $0.62
Upside: +224.62%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $3.76
Upside: -46.74%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $139.16
Upside: +14.98%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $3.49
Upside: +587.68%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.15
Upside: +249.34%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $300.16
Upside: +24.93%
Dec 15, 2022
Initiates: Sell
Price Target: $13
Current: $11.28
Upside: +15.25%
May 24, 2022
Maintains: Neutral
Price Target: $6 → $4
Current: $1.43
Upside: +179.72%